MOUNJARO
Drug timelines are a Plus or Pro feature.
34 regulatory and trial events tracked for MOUNJARO, covering 2022-05-13 to 2026-08-28. Get the full timeline:
Most recent: EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.
34 regulatory and trial events tracked for MOUNJARO, covering 2022-05-13 to 2026-08-28. Get the full timeline:
Most recent: EMA Authorised: Mounjaro (tirzepatide) — Eli Lilly Nederland B.V.